FDA approves new drugs
· On Dec. 8, the U.S. Food and Drug Administration (FDA) approved: · Vonvendi, von Willebrand factor (Recombinant), for use in adults 18 years…
News
FDA approves new treatment for multiple myeloma
On Nov. 30, the U.S. Food and Drug Administration (FDA) approved Empliciti (elotuzumab) in combination with two other therapies to treat people with multiple…
FDA approves new drugs
· On Nov. 16, the U.S. Food and Drug Administration (FDA) granted accelerated approval for Darzalex (daratumumab) to treat patients with multiple myeloma who…
FDA approves new treatment for advanced melanoma
On Nov. 10, the U.S. Food and Drug Administration (FDA) approved Cotellic (cobimetinib) to be used in combination with vemurafenib to treat advanced melanoma…
FDA approves new drug for severe asthma
On Nov. 4, the U.S. Food and Drug Administration (FDA) approved Nucala (mepolizumab) for use with other asthma medicines for the maintenance treatment of…
FDA approves new melanoma treatments
On Oct. 28, the U.S. Food and Drug Administration (FDA) expanded the approved use of Yervoy (ipilimumab) to include a new use as adjuvant…
FDA approves new drug for hyperkalemia
On Oct. 22, the U.S. Food and Drug Administration (FDA) approved eltassa (patiromer for oral suspension) to treat hyperkalemia. Read more.
FDA approves new drug for pancreatic cancer
On Oct. 22, the U.S. Food and Drug Administration (FDA) approved Onivyde (irinotecan liposome injection), in combination with fluorouracil and leucovorin, to treat patients…
FDA approves new drug for metastatic lung cancer
On Oct. 9, the U.S. Food and Drug Administration (FDA) approved Opdivo (nivolumab) to treat patients with metastatic non-small cell lung cancer whose disease…
FDA approves new injectable drug for schizophrenia
On Oct. 6, the U.S. Food and Drug Administration (FDA) approved Aristada (aripiprazole lauroxil) extended-release injection to treat adults with schizophrenia. Read more
FDA launches campaign to reduce youth smoking
On Oct. 7, the U.S. Food and Drug Administration (FDA) announced the launch of a national public education campaign to prevent and reduce tobacco…
FDA approves new drugs
· On Dec. 8, the U.S. Food and Drug Administration (FDA) approved: · Vonvendi, von Willebrand factor (Recombinant), for use in adults…
FDA approves new treatment for multiple myeloma
On Nov. 30, the U.S. Food and Drug Administration (FDA) approved Empliciti (elotuzumab) in combination with two other therapies to treat people…
FDA approves new drugs
· On Nov. 16, the U.S. Food and Drug Administration (FDA) granted accelerated approval for Darzalex (daratumumab) to treat patients with multiple…
FDA approves new treatment for advanced melanoma
On Nov. 10, the U.S. Food and Drug Administration (FDA) approved Cotellic (cobimetinib) to be used in combination with vemurafenib to treat…
FDA approves new drug for severe asthma
On Nov. 4, the U.S. Food and Drug Administration (FDA) approved Nucala (mepolizumab) for use with other asthma medicines for the maintenance…
FDA approves new melanoma treatments
On Oct. 28, the U.S. Food and Drug Administration (FDA) expanded the approved use of Yervoy (ipilimumab) to include a new use…
FDA approves new drug for hyperkalemia
On Oct. 22, the U.S. Food and Drug Administration (FDA) approved eltassa (patiromer for oral suspension) to treat hyperkalemia. Read more.
FDA approves new drug for pancreatic cancer
On Oct. 22, the U.S. Food and Drug Administration (FDA) approved Onivyde (irinotecan liposome injection), in combination with fluorouracil and leucovorin, to…
FDA approves new drug for metastatic lung cancer
On Oct. 9, the U.S. Food and Drug Administration (FDA) approved Opdivo (nivolumab) to treat patients with metastatic non-small cell lung cancer…
FDA approves new injectable drug for schizophrenia
On Oct. 6, the U.S. Food and Drug Administration (FDA) approved Aristada (aripiprazole lauroxil) extended-release injection to treat adults with schizophrenia. Read…
FDA launches campaign to reduce youth smoking
On Oct. 7, the U.S. Food and Drug Administration (FDA) announced the launch of a national public education campaign to prevent and…
Poll
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.